Cardiovascular disease (CVD) in older adults has been associated with varying degrees of cognitive dysfunction. Several mechanisms may explain this association, including impaired cardiovascular reactivity to autonomic nervous system (ANS) signaling. Reduced heart rate recovery following a stress test may be considered an indication of impaired ANS function (i.e., reduced parasympathetic activity). Participants were 47 older adults (53–83 years) who underwent a treadmill stress test and were administered a comprehensive neuropsychological battery upon entry to phase II cardiac rehabilitation. Reduced parasympathetic activity was associated with impaired cognitive performance on a measure of global cognitive function and on tasks of speeded executive function and confrontation naming. These relationships suggest that changes in autonomic function may be mechanistically related to the impaired cognitive function prevalent in CVD patients.
1. Introduction
Cardiovascular disease (CVD) is associated with varying degrees of cognitive impairment, ranging from minimal difficulties (“brain at risk stage”) to dementia [1–4] and is associated with cognitive decline above and beyond the normal aging process [5]. Impaired cognitive function is observed in persons with CVD, even in the absence of major cardiac events [6]. Older adults with CVD frequently report experiencing significant cognitive dysfunction in everyday life and men with CVD demonstrate a reduction in cognitive function equivalent to approximately four to five years of additional age [7, 8]. These findings are in addition to the known associated between CVD and severe neurological conditions like stroke and Alzheimer’s disease [9, 10].
Several pathophysiological mechanisms associated with CVD contribute to the observed cognitive dysfunction in this population. For example, systemic hypoperfusion is common and associated with reduced cognitive test performance [11–13]. Similarly, CVD is associated with development of white matter disease [14], pathological changes to blood vessels [15], and inflammatory processes [16], each of which are known to adversely impact cognitive function. Recent work implicates disrupted autonomic nervous system (ANS) signaling as another potential mechanism for the cognitive impairment, as both blood pressure variability (e.g., standard deviation of systolic blood pressure) and heart rate variability have been linked to neurocognitive outcome in persons with CVD [17–19].
Such findings suggest that other, more easily obtained ANS indices may also be associated with reduced cognitive function and provide insight into potential mechanisms. One such ANS index is heart rate recovery, which may be operationally defined as the change from peak HR following maximal exercise (typically during treadmill stress testing) to that measured after two minutes of recovery [18]. This commonly used ANS index is sensitive to parasympathetic activity, as the return to resting HR following exercise termination is predominately accomplished via vagus nerve activity [19–21].
To help clarify the association between HR recovery and cognitive function, we assessed a sample of both men and women (age range 53–83 years) with a wide range of CVD conditions using a comprehensive neuropsychological test battery and a treadmill stress test. We hypothesized that ANS dysfunction would be associated with poorer cognitive function, such that greater HR recovery would correspond to better cognitive function.
2. Methods 2.1. Participants
The study sample included 47 (32 men, 15 female) older adults enrolled in a prospective study of the neurocognitive consequences of CVD. All participants were referred by their cardiologists for enrollment into a large cardiac rehabilitation program; information regarding the type of CVD event or condition diagnosis which prompted referral to cardiac rehabilitation can be found in Table 1. The mean time interval between the CVD event or condition diagnosis and the stress test is 36.3 days (minimum = 8, maximum = 147; median = 34). Participants in the study sample had a wide range of CVD conditions, including arrhythmia, atrial fibrillation, coronary artery bypass graft (CABG), valve surgery, cardiac arrest, myocardial infarction, heart failure, and hypertension; see Table 1.
Demographic characteristics, clinical conditions, reasons for referral to cardiac rehabilitation, cardiovascular indices, and neuropsychological test performance (N=47).
Demographics
Mean (SD)
Range
Age (years)
67.87 (8.92)
53–83
Education (years)
14.07 (2.61)
7–20
Male, N(%)
32 (68%)
15
Clinical conditions
Percentage with condition
Arrhythmia
2%
Atrial fibrillation
11%
Coronary artery bypass graft (CABG)
23%
Cardiac arrest
2%
Diabetes (type II)
26%
Myocardial infarction (MI)
21%
Heart failure
15%
High cholesterol
28%
Hypertension
43%
β-blocker usage
68%
Type of event or condition prompting referral to cardiac rehabilitation
Number of participants
Percentage of participants
Ablation
1
2%
Angina
5
11%
Aortic valve repair
1
2%
CABG
8
17%
MI
6
13%
Mitral valve repair
3
6%
Stent
21
45%
Valve replacement
2
4%
Cardiovascular indices
Mean (SD)
Range; median
HRrest*
66.6 (11.9)
40–96; 65
HRpeak
112.7 (19.5)
60–159; 115
METspeak
7.3 (3.2)
1.0–14.5; 7.0
HR2min-post
81.0 (18.2)
43–126; 80
Heart rate recovery
31.7 (15.2)
0–67; 31
Neuropsychological test performance
Mean (SD)
Range
MMSE
28.4 (1.5)
25–30
3MS
95 (4.1)
83–100
TMT-A time (seconds)
36.9 (11.7)
22–82
TMT-B time (seconds)
97.3 (49.9)
42–325
LNS total score
8.9 (3.00)
2–15
FAB total score
16.4 (1.7)
11–18
Pegs, dominant hand time (seconds)
103.4 (52.5)
56–398
HVLT learning
21.9 (5.5)
10–33
HVLT delayed recall
7.2 (3.4)
0–12
HVLT true hits
11.0 (1.2)
7–12
BNT short form total score
14.3 (0.9)
12–15
Animal Naming
18.3 (5.2)
7–33
*Data regarding resting HR (HRrest) were missing for 1 of the 47 participants.
The exclusion criteria in the current student included (1) current signs of dementia (as defined by a score lower than 24 on the Mini Mental Status Exam (MMSE)) [23], (2) history of a major neurological disorder such as Alzheimer’s disease, Parkinson’s disease, seizures, large vessel stroke, or loss of consciousness >10 minutes, and (3) history of major psychiatric disorder such as schizophrenia, bipolar illness, or substance abuse. In addition, no participants with new onset or chronic atrial arrhythmia were included in the study sample. Participants were not selected based on concerns regarding possible cognitive dysfunction. Participants averaged 67.87 ± 8.92 years of age and 14.07 ± 2.61 years of education. All participants were Caucasian.
On the basis of medical chart review, clinically relevant conditions (i.e., arrhythmia, atrial fibrillation, coronary artery bypass graft (CABG), cardiac arrest, type II diabetes, myocardial infarction, heart failure, high cholesterol, hypertension, and β-blocker usage) were coded as either present or absent; see Table 1.
2.2. Measures2.2.1. Exercise Stress Testing
Resting HR, peak HR, exercise capacity, and HR recovery values for each participant were obtained using a treadmill exercise test. The treadmill exercise test was conducted according to a modified ramp protocol using a Quinton Medtrack ST55 treadmill (Quinton Cardiology, Deerfield, WI). More specifically, the exercise protocol was characterized by an increase in mill elevation every 60 seconds that approximates a relative increase in workload of 15% holding speed constant, as well as an increase in speed every 3 minutes that also reflects an approximate relative increase in workload of 15% from the previous stage. The test was terminated if the patient showed clinical signs of cardiovascular, neurological, or musculoskeletal decompensation, or at the patient’s request; such practice is consistent with American College of Cardiology/American Heart Association and American College of Sports Medicine published guidelines for exercise stress testing [24–26]. Exercise capacity was estimated in metabolic equivalents (METS) at this peak volition or symptom limited end point [24].
In the present study, HR recovery was operationally defined as the difference in beats per minute (bpm) between peak HR (i.e., HR at exercise termination) and HR two minutes after exercise termination [20, 21, 27]. Although HR recovery has also been computed from HR one minute after exercise termination, HR recovery at 2 minutes predicted mortality better than other indices in a large study of male patients completing treadmill tests and coronary angiography [28], and, in another study, only HR recovery at 2 minutes predicted the presence of coronary artery disease [29]. In a validation study including 2,193 men, the average drop in HR at 2 minutes was 31.7±13.1, and a reduction in HR of less than 22 bpm within 2 minutes following peak exercise was considered “abnormal” [28].
2.2.2. Neuropsychological Tests
All participants completed a neuropsychological test battery comprised of tasks commonly used during clinical neuropsychological evaluation; see Table 1. The following four domains were assessed.
Global cognitive functioning using the Modified Mini Mental Status (3MS) [30].
Attention/executive function/psychomotor speed using the Trail Making Test A and B (TMT-A and TMT-B) [31], Letter-Number Sequencing (LNS) [32], Frontal Assessment Battery (FAB) [33], and Grooved Pegboard (Pegs) [34] dominant hand.
Memory using the Hopkins Verbal Learning Test (HVLT)—revised [35].
Language using the Boston Naming Test (BNT)—short form [22] and Animal Naming (animals) [36].
2.3. Procedure
All procedures were approved by the Institutional Review Board of the associated university prior to study onset. All participants provided written informed consent prior to study participation. Exercise stress testing was completed upon entry into cardiac rehabilitation. All neuropsychological instruments were individually administered by trained research team members. Neuropsychological testing was completed within 14 days of the exercise stress test.
2.4. Data Analysis
In preliminary analyses, descriptive data regarding participant demographic characteristics, clinical conditions, cardiovascular indices, and neuropsychological test performance were generated. The primary analyses consisted of a series of partial correlations between HR recovery and the neuropsychological test performance variables. Control variables included those factors with known importance for HRR and/or cognitive function in older adults with CVD, specifically sex, age, years of education, β-blocker usage, and exercise capacity (as measured by METS at peak HR). Finally, in order to evaluate the relative strength of the findings, effect size values (i.e., Cohen’s d) were calculated for all partial correlations.
Previous research has documented a relationship depression and HR recovery in a very similar sample of phase II cardiac rehabilitation patients [21]. All participants in the present study completed the Beck Depression Inventory (BDI) [37] as part of the cardiac rehabilitation program. However, BDI total score was not significantly correlated with any of the neuropsychological test performance variables. In the absence of such correlation, the primary analyses were not adjusted for BDI scores.
3. Results
Participant demographic characteristics, clinical conditions, cardiovascular indices, reasons for referral to cardiac rehabilitation, and neuropsychological test performance are presented in Table 1. Of note, HR recovery values ranged from 0 bpm to 67 bpm (M=31.7, SD=15.2).
Partial correlations and Cohen’s d effect sizes between HR recovery and the neuropsychological test performance variables are presented in Table 2. After adjusting for relevant variables (i.e., sex, age, years of education, β-blocker usage, and exercise capacity), HR recovery was significantly correlated with 3MS total score (r=.42, P=.006), BNT short-form total score (r=.40, P=.008), and TMT-B time to completion (r=-.33, P=.03). Associations for 3MS and BNT short form indicate large effect sizes (Cohen’s d values of .93 and .87, resp.), while the association for TMT-B indicates a medium effect (Cohen’s d=.70). The correlations between HR recovery and both TMT-A time to completion (r=-.28, P=.08) and grooved pegboard time to completion (r=-.28, P=.08) approached statistical significance and were consistent with a medium effect size (Cohen’s d=.58 for both measures).
Correlations between heart rate recovery and neuropsychological test performance, controlling for sex, age, years of education, β-blocker usage, and METS at peak HR (N=47).
Heart rate recovery
Partial correlation r (P value)
Cohen’s d effect size
3MS
.42 (.006)**
.93c
TMT-A time (seconds)
−.28 (.07)
.58b
TMT-B time (seconds)
−.33 (.03)*
.70b
LNS total score
.17 (.29)
.35a
FAB total score
.12 (.44)
.24a
Pegs, dominant hand time (seconds)
−.28 (.08)
.58b
HVLT learning
.19 (.23)
.39a
HVLT delayed recall
.15 (.35)
.30a
HVLT true hits
.25 (.11)
.52b
BNT—short form total score
.40 (.008)**
.87c
Animal naming
.13 (.41)
.26a
*
P <.05, **P <.01; Cohen’s d values of 0.2, 0.5, and 0.8 are the minimum thresholds for a small effecta, medium effectb, and large effectc sizes, respectively [22].
4. Discussion
The results of the present study indicate that greater heart rate recovery two minutes after exercise termination is associated with better performance in multiple cognitive domains, including global cognitive function, speeded executive function, and language. Several aspects of these findings warrant brief discussion.
The current findings extend previous research [38] and demonstrate that the relationships between ANS-mediated cardiovascular functioning and cognitive tasks are independent of cardiovascular fitness (as measured by exercise capacity). Although the specific mechanisms underlying these associations are currently unknown, we offer several candidate explanations. One likely explanation involves the effects of ANS dysregulation on vascular processes. Endothelial dysfunction and impaired cardiovascular reactivity to ANS signaling are common in CVD patients [39–44] and have been suggested as a contributor to cognitive dysfunction in other studies [45]. An additional explanation implicates the inflammatory cytokines of the vagus nerve; more specifically, both slowed HR recovery and cognitive dysfunction may be a reflection of an underlying dysregulation of the cholinergic anti-inflammatory pathway [46]. Another possibility is that poorer HR recovery and cognitive function reflect structural brain changes such as white matter disease or reduced integrity of white matter pathways. For example, the anterior cingulate cortex is important for both ANS functioning and frontal lobe-mediated functions (e.g., attention/executive function/psychomotor speed) [47, 48] and damage in this region could well affect both indices. Future neuroimaging studies utilizing standard imaging and diffusion tensor imaging technology [49] will help to clarify this possibility.
Identifying a relationship between a measure of cardiac function and measures of global cognitive function and speeded executive function is consistent with past studies [50, 51]. However, finding an association between HR recovery and language function is less common. One possibility is that HR recovery is an underlying marker for neurodegenerative conditions with known language impairment, such as Alzheimer’s disease. CVD has long been known as a risk factor for Alzheimer’s disease [52, 53]. Persons with Alzheimer’s disease exhibiting autonomic cardiac dysfunction [54], manifesting as a relatively hypersympathetic and hypo-parasympathetic state [55]. Thus, it may be possible that indices of ANS function (e.g., HR recovery, HR variability) may prove to be proximal predictors of Alzheimer’s disease [56].
The current findings are limited in several ways. First, due to the cross-sectional design of the present study, it is not clear whether the association between HR recovery and cognitive function simply represents a cooccurrence or reflects a casual relationship. Future studies with a longitudinal design may clarify this issue. Longitudinal investigations may also examine whether improvements in HR recovery correspond with the cognitive improvements found in CVD patients in cardiac rehabilitation [57–59]. Second, the present study examined cognitive functioning within a diverse group of CVD conditions and did not attempt to make any differentiation among them. Although the medium to large effect sizes suggest the findings are robust, replication and extension of the current findings in larger samples with more narrowly defined CVD patient samples are needed. Similarly, future studies should also examine the association between HR recovery and cognitive function in older adults without CVD to help clarify possible mechanisms for this pattern.
In brief summary, the current study extends past work to show that HR recovery following a treadmill stress test (an index of autonomic nervous system function) is related to multiple cognitive domains, including global cognitive functioning, speeded executive function, and language abilities. Further work is needed to clarify possible mechanisms for these findings and to explore potential for therapeutic improvement.
DesmondD. W.The neuropsychology of vascular cognitive impairment: is there a specific cognitive deficit?20042261-2372-s2.0-864422053510.1016/j.jns.2004.09.002RafnssonS. B.DearyI. J.SmithF. B.WhitemanM. C.FowkesF. G. R.Cardiovascular diseases and decline in cognitive function in an elderly community population: the Edinburgh Artery study20076954254342-s2.0-3425081016810.1097/psy.0b013e318068fce4TrojanoL.IncalziR. A.AcanforaD.PiconeC.MecocciP.RengoF.Cognitive impairment: a key feature of congestive heart failure in the elderly200325012145614632-s2.0-164247166810.1007/s00415-003-0249-3HachinskiV.Vascular dementia: a radical redefinition199453-41301322-s2.0-0028302251OkonkwoO. C.CohenR. A.GunstadJ.TremontG.AloscoM. L.PoppasA.Longitudinal trajectories of cognitive decline among older adults with cardiovascular disease20103043623732-s2.0-7795519758810.1159/000319564DuronE.HanonO.Vascular risk factors, cognitve decline, and dementia2008423633812-s2.0-44049089120ElwoodP. C.PickeringJ.BayerA.GallacherJ. E. J.Vascular disease and cognitive function in older men in the Caerphilly cohort200231143482-s2.0-003618501010.1093/ageing/31.1.43KhatriP.BabyakM.ClancyC.DavisR.CroughwellN.NewmanM.RevesJ. G.MarkD. B.BlumenthalJ. A.Perception of cognitive function in older adults following coronary artery bypass surgery19991833013062-s2.0-003296412610.1037/0278-6133.18.3.301KivipeltoM.HelkalaE. L.LaaksoM. P.HänninenT.HallikainenM.AlhainenK.SoininenH.TuomilehtoJ.NissienA.Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study20013227300144714512-s2.0-0035897938WittB. J.BallmanK. V.BrownR. D.Jr.MeverdenR. A.JacobsenS. J.RogerV. L.The incidence of stroke after myocardial infarction: a meta-analysis20061194354.e1354.e92-s2.0-3364522647110.1016/j.amjmed.2005.10.058JeffersonA. L.PoppasA.PaulR. H.CohenR. A.Systemic hypoperfusion is associated with executive dysfunction in geriatric cardiac patients20072834774832-s2.0-3384658253610.1016/j.neurobiolaging.2006.01.001RománG. C.Brain hypoperfusion: a critical factor in vascular dementia20042654544582-s2.0-304277055010.1179/016164104225017686RománG. C.Vascular dementia prevention: a risk factor analysis200520supplement 2911002-s2.0-3364479523310.1159/000089361LongstrethW. T.ArnoldA. M.BeauchampN. J.ManolioT. A.LefkowitzD.JungreisC.HirschC. H.O'LearyD. H.FurbergC. D.Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: the cardiovascular health study200536156612-s2.0-1114422388810.1161/01.STR.0000149625.99732.69MoserD. J.HothK. F.RobinsonR. G.PaulsenJ. S.SinkeyC. A.BenjaminM. L.SchultzS. K.HaynesW. G.Blood vessel function and cognition in elderly patients with atherosclerosis20043511e369e3722-s2.0-21644475581GunstadJ.BaussermanL.PaulR. H.TateD. F.HothK.PoppasA.JeffersonA. L.CohenR. A.C-reactive protein, but not homocysteine, is related to cognitive dysfunction in older adults with cardiovascular disease20061355405462-s2.0-3374494459010.1016/j.jocn.2005.08.010OkonkwoO. C.CohenR. A.GunstadJ.PoppasA.Cardiac output, blood pressure variability, and cognitive decline in geriatric cardiac patients2011312902972-s2.0-7995941743410.1097/HCR.0b013e318220a817ShahA. J.SuS.VeledarE.BremnerJ. D.GoldsteinF. C.LampertR.GoldbergJ.VaccarinoV.Is heart rate variability related to memory performance in middle-aged men?20117364754822-s2.0-7996035628310.1097/PSY.0b013e3182227d6aThayerJ. F.HansenA. L.Saus-RoseE.JohnsenB. H.Heart rate variability, prefrontal neural function, and cognitive performance: the neurovisceral integration perspective on self-regulation, adaptation, and health20093721411532-s2.0-6764945819310.1007/s12160-009-9101-zColeC. R.FoodyJ. M.BlackstoneE. H.LauerM. S.Heart rate recovery after submaximal exercise testing as a predictor of mortality in a cardiovascularly healthy cohort200013275525552-s2.0-0034603691HughesJ. W.CaseyE.LuysterF.DoeV. H.WaechterD.RosneckJ.JosephsonR.Depression symptoms predict heart rate recovery after treadmill stress testing200615151129.e11129.e62-s2.0-3364608009710.1016/j.ahj.2006.02.019KaplanE.GoodglassH.WeintraubS.19832ndPhiladelphia, Pa, USALea and FebingerFolsteinM. F.FolsteinS. E.McHughP. R.‘Mini mental state’: a practical method for grading the cognitive state of patients for the clinician19751231891982-s2.0-001682381010.1016/0022-3956(75)90026-6American College of Sports Medicine20006Philadelphia, Pa, USAWilliams & WilkinsFletcherG. F.BaladyG. J.AmsterdamE. A.ChaitmanB.EckelR.FlegJ.FroelicherV. F.LeonA. S.PiñaI. L.RodneyR.Simons-MortonD. G.WilliamsM. A.BazzarreT.Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association200110414169417402-s2.0-0035797845GibbonsR. J.BaladyG. J.BrickerJ. T.BrickerJ. T.ChaitmanB. R.FletcherG. F.FroelicherV. F.MarkD. B.McCallisterB. D.MoossA. N.O'ReillyM. G.WintersW. L.AntmanE. M.AntmanE. M.AlpertJ. S.AlpertJ. S.FaxonD. P.FaxonD. P.FusterV.FusterV.GregoratosG.GregoratosG.HiratzkaL. F.HiratzkaL. F.JacobsA. K.JacobsA. K.RussellR. O.RussellR. O.SmithS. C.SmithS. C.SmithS. C.ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association task force on practice guidelines2002408153115402-s2.0-003712098410.1016/S0735-1097(02)02164-2LipinskiM. J.VetrovecG. W.FroelicherV. F.Importance of the first two minutes of heart rate recovery after exercise treadmill testing in predicting mortality and the presence of coronary artery disease in men20049344454492-s2.0-124229297710.1016/j.amjcard.2003.10.039ShetlerK.MarcusR.FroelicherV. F.VoraS.KalisettiD.PrakashM.DoD.MyersJ.Heart rate recovery: validation and methodologic issues2001387198019872-s2.0-003519613710.1016/S0735-1097(01)01652-7LipinskiM. J.VetrovecG. W.FroelicherV. F.Importance of the first two minutes of heart rate recovery after exercise treadmill testing in predicting mortality and the presence of coronary artery disease in men20049344454492-s2.0-124229297710.1016/j.amjcard.2003.10.039TengE. L.ChuiH. C.The Modified Mini-Mental State (3MS) examination19874883143182-s2.0-0023194048ReitanR. M.WolfsonD.19932ndSouth Tucson, Ariz, USANeuropsychology PressWechslerD.19973rdSan Antonio, Tex, USAThe Psychological CorporationDuboisB.SlachevskyA.LitvanI.PillonB.The FAB: a frontal assessment battery at bedside20005511162116262-s2.0-0034642168KløveH.ForsterF. M.Clinical neuropsychology1963New York, NY, USASaunders16471658BrandtJ.The Hopkins Verbal Learning Test: development of a new memory test with six equivalent forms1991521251422-s2.0-0025890255EslingerP.DamasioA. R.BentonA. L.1984Iowa City, Iowa, USADepartment of Neurology, Division of Behavioral NeurologyBeckA. T.RushA. J.ShawB. F.EmeryG.1979New York, NY, USAGuilford PressHansenA. L.JohnsenB. H.SollersJ. J.IIIStenvikK.ThayerJ. F.Heart rate variability and its relation to prefrontal cognitive function: the effects of training and detraining20049332632722-s2.0-884426690010.1007/s00421-004-1208-0CarneyR. M.FreedlandK. E.VeithR. C.Depression, the autonomic nervous system, and coronary heart disease200567supplement 1S29S332-s2.0-1404426103910.1097/01.psy.0000162254.61556.d5DekkerJ. M.CrowR. S.FolsomA. R.HannanP. J.LiaoD.SwenneC. A.SchoutenE. G.Low heart rate variability in a 2-minute rhythm strip predicts risk of coronary heart disease and mortality from several causes: the ARIC study200010211123912442-s2.0-0034641646HarrisK. F.MatthewsK. A.Interactions between autonomic nervous system activity and endothelial function: a model for the development of cardiovascular disease20046621531642-s2.0-164229134710.1097/01.psy.0000116719.95524.e2HassanA.HuntB. J.O'SullivanM.BellR.D'SouzaR.JefferyS.BamfordJ. M.MarkusH. S.Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction200412712122192-s2.0-034609787910.1093/brain/awh023HijmeringM. L.StroesE. S. G.OlijhoekJ.HuttenB. A.BlankestijnP. J.RabelinkT. J.Sympathetic activation markedly reduces endothelium-dependent, flow-mediated vasodilation20023946836882-s2.0-003713852110.1016/S0735-1097(01)01786-7NekiN. S.SinghR. B.RastogiS. S.How brain influences neuro-cardiovascular dysfunction2004522232302-s2.0-13744257389HothK. F.TateD. F.PoppasA.FormanD. E.GunstadJ.MoserD. J.PaulR. H.JeffersonA. L.HaleyA. P.CohenR. A.Endothelial function and white matter hyperintensities in older adults with cardiovascular disease20073823083122-s2.0-3384663418710.1161/01.STR.0000254517.04275.3fTraceyK. J.Physiology and immunology of the cholinergic antiinflammatory pathway200711722892962-s2.0-3384681749810.1172/JCI30555CritchleyH. D.MathiasC. J.JosephsO.O'DohertyJ.ZaniniS.DewarB. K.CipolottiL.ShalliceT.DolanR. J.Human cingulate cortex and autonomic control: converging neuroimaging and clinical evidence200312610213921522-s2.0-024236794410.1093/brain/awg216MatthewsS. C.PaulusM. P.SimmonsA. N.NelesenR. A.DimsdaleJ. E.Functional subdivisions within anterior cingulate cortex and their relationship to autonomic nervous system function2004223115111562-s2.0-304268373410.1016/j.neuroimage.2004.03.005DaSilvaA. F.TuchD. S.WiegellM. R.HadjikhaniN.A primer on diffusion tensor imaging of anatomical substructures2003151E1E42-s2.0-6044230559VicarioA.MartinezC. D.BarettoD.Diaz CasaleA.NicolosiL.Hypertension and cognitive decline: impact on executive function20057105986042-s2.0-33645047211VinkersD. J.StekM. L.van der MastR. C.de CraenA. J. M.Le CessieS.JollesJ.WestendorpR. G. J.GusseklooJ.Generalized atherosclerosis, cognitive decline, and depressive symptoms in old age20056511071122-s2.0-2204443318710.1212/01.wnl.0000167544.54228.95de La TorreJ. C.How do heart disease and stroke become risk factors for Alzheimer's disease?20062866376442-s2.0-3374895137010.1179/016164106X130362NewmanA. B.FitzpatrickA. L.LopezO.JacksonS.LyketsosC.JagustW.IvesD.DeKoskyS. T.KullerL. H.Dementia and Alzheimer's disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort2005537110111072-s2.0-2434445127910.1111/j.1532-5415.2005.53360.xGiubileiF.StranoS.ImbimboB. P.TiseiP.CalcagniniG.LinoS.FrontoniM.SantiniM.FieschiC.Cardiac autonomic dysfunction in patients with Alzheimer disease: possible pathogenetic mechanisms19981243563612-s2.0-0032449909Aharon-PeretzJ.HarelT.RevachM.Ben-HaimS. A.Increased sympathetic and decreased parasympathetic cardiac innervation in patients with Alzheimer's disease19924999199222-s2.0-0026713393ZulliR.NicosiaF.BorroniB.AgostiC.PromettiP.DonatiP.de VecchiM.RomanelliG.GrassiV.PadovaniA.QT dispersion and heart rate variability abnormalities in Alzheimer's disease and in mild cognitive impairment20055312213521392-s2.0-2934446148510.1111/j.1532-5415.2005.00508.xMyersJ.HadleyD.OswaldU.BrunerK.KottmanW.HsuL.DubachP.Effects of exercise training on heart rate recovery in patients with chronic heart failure20071536105610632-s2.0-3424974894510.1016/j.ahj.2007.02.038GunstadJ.MacGregorK. L.PaulR. H.PoppasA.JeffersonA. L.TodaroJ. F.CohenR. A.Cardiac rehabilitation improves cognitive performance in older adults with cardiovascular disease20052531731762-s2.0-19944386607TiukinhoyS.BeoharN.HsieM.Improvement in heart rate recovery after cardiac rehabilitation200323284872-s2.0-003734488610.1097/00008483-200303000-00002